Interestingly, however, there is new evidence of the potential link between LCN2 and the progression of chronic kidney disease -mineral bone disorder (CKD-MBD) as well as catabolic effects of LCN2 in OA joints [90,91]. Here, LCN2 is linked to Marchiafava-Bignami disease.